DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
All 50 states tracked. 14 cover weight-loss GLP-1s with PA, 23 require PA evidence, 13 exclude weight-loss indication. Diabetes coverage is standard nationwide.
State Medicaid covers FDA-approved weight-loss GLP-1s (Wegovy, Zepbound) for eligible patients.
Coverage available with prior authorization. Documentation of BMI, comorbidity, and prior weight-loss efforts typically required.
State Medicaid does not cover weight-loss-only indications. Type 2 diabetes coverage may still apply for Ozempic and Mounjaro.
Editorial summary, not legal or medical advice. State Medicaid policies change frequently. Confirm with your prescriber or your state Medicaid member services before relying on any single source.